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Purpose: Epidural analgesia has been the preferred analgesic technique after major 
abdominal surgery. On the other hand, the combined use of intrathecal morphine 
(ITM) and intravenous patient controlled analgesia (IVPCA) has been shown to be 
a viable alternative approach for analgesia. We hypothesized that ITM combined 
with IVPCA is as effective as patient controlled thoracic epidural analgesia (PC-
TEA) with respect to postoperative pain control after conventional open gastrecto-
my. Materials and Methods: Sixty-four patients undergoing conventional open 
gastrectomy due to gastric cancer were randomly allocated into the intrathecal mor-
phine combined with intravenous patient-controlled analgesia (IT) group or patient-
controlled thoracic epidural analgesia (EP) group. The IT group received preopera-
tive 0.3 mg of ITM, followed by postoperative IVPCA. The EP group preoperatively 
underwent epidural catheterization, followed by postoperative PCTEA. Visual ana-
log scale (VAS) scores were assessed until 48 hrs after surgery. Adverse effects re-
lated to analgesia, profiles associated with recovery from surgery, and postoperative 
complications within 30 days after surgery were also evaluated. Results: This study 
failed to demonstrate the non-inferiority of ITM-IVPCA (n=29) to PCTEA (n=30) 
with respect to VAS 24 hrs after surgery. Furthermore, the IT group consumed more 
fentanyl than the EP group did (1247.2±263.7 μg vs. 1048.9±71.7 μg, p<0.001). 
The IT group took a longer time to ambulate than the EP group (p=0.021) and had 
higher incidences of postoperative ileus (p=0.012) and pulmonary complications 
(p=0.05) compared with the EP group. Conclusion: ITM-IVPCA is not as effective 
as PCTEA in patients undergoing gastrectomy, with respect to pain control, ambula-
tion, postoperative ileus and pulmonary complications.
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INTRODUCTION
Recently, the combined use of intrathecal morphine (ITM) and intravenous patient 
controlled analgesia (IVPCA) has been shown to be a viable alternative approach 
for analgesia after major abdominal surgery.1,2 Several studies reported that ITM-
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gastrectomy for stomach cancer were included. The exclu-
sion criteria were as follows: presence of spinal deformity or 
spinal disease; pulmonary, hepatic or renal disease; any con-
traindication to epidural or intrathecal injection; allergy to 
fentanyl and local anesthetics; inability to understand the 
pain scale; and any type of chronic pain or current opioid 
use. After written informed consent was obtained, patients 
were instructed on how to use the device for patient-con-
trolled analgesia (PCA) and how to report pain via the visual 
analogue scale (VAS) the day before surgery.
By using a table of random sampling numbers, patients 
were randomly allocated into either the intrathecal mor-
phine combined with intravenous patient-controlled analge-
sia (IT) group (receiving ITM-IVPCA, n=32) or patient-
controlled thoracic epidural analgesia (EP) group (receiving 
PCTEA, n=32) on the day of the surgery. 
Perioperative pain management
In the EP group, an epidural catheter was placed before the 
induction of general anesthesia. Under standard monitor-
ing, the epidural catheter was inserted at the level of T8--T9 
or T9--T10 via a 17-gauge Touhy needle and advanced 5 cm 
into the epidural space. Intravascular or subarachnoid place-
ment of the epidural catheter was ruled out by confirming 
that no blood or cerebrospinal fluid was aspirated. Also, 3 
mL of 1% lidocaine was administered. If there was no rapid 
onset of neuroaxial block, suggesting intrathecal delivery of 
the local anesthetic, the placement of the epidural catheter 
was completed. After 30 min, sensory block around the lev-
el of T8--T10 was tested by pinprick. Before the induction 
of anesthesia, 5 mL of a mixture of 0.2% ropivacaine and 4 
μg/mL of fentanyl was administered through the epidural 
catheter. It was administered once more upon peritoneal 
closure, and then a pump for patient-controlled analgesia 
(Accufusor Plus®, Woo Young Medical Co., Ltd., Seoul, 
Korea), containing a mixture of 0.2% ropivacaine and 4 μg/
mL of fentanyl (total volume, 250 mL), was connected to 
the epidural catheter. The basal infusion of the pump was set 
at 5 mL/hr with a 0.5 mL bolus doses allowed every 15 min. 
In the IT group, 0.3 mg of morphine in 0.9% saline solu-
tion (total volume 4 mL) was administered into the intrathe-
cal space via a 27-gauge pencil-point spinal needle placed at 
the level of L3--L4, before the induction of general anesthe-
sia. Upon peritoneal closure, 1 μg/kg of fentanyl was ad-
ministered intravenously, and the same pump used in the 
EP group containing 20 μg/kg of fentanyl in 0.9% saline 
solution (total volume 250 mL) was connected. IVPCA 
IVPCA offered similar or even better analgesia compared 
to patient controlled epidural analgesia in patients under-
going hepato-pancreato-biliary surgery3 or laparoscopic 
colorectal surgery.4 Furthermore, there were reports that 
ITM-IVPCA compared to epidural analgesia is associated 
with a lower or similar incidence of respiratory complica-
tion and a better recovery profile such as shorter hospital 
stay in hepato-pancreato-biliary surgery3 or laparoscopic 
colorectal surgery.4,5 
On the other hand, epidural analgesia remained the pre-
ferred analgesic technique in patients undergoing major ab-
dominal surgery because it provides good pain control,6 im-
proved respiratory function,7 and decreased chest-related 
morbidity.8 For epidural analgesia in patients undergoing 
conventional open gastrectomy, an epidural catheter is rec-
ommended to be placed at the level of the thoracic spine. In-
serting a epidural catheter at the thoracic level is known to 
be procedurally difficult.9 Additionally, neurological compli-
cations related to neuraxial blockade were reported to occur 
more often after an epidural than spinal block.10 Therefore, if, 
in patients undergoing gastrectomy, the ITM-IVPCA could 
provide similar analgesia and recovery profile, compared to 
patient-controlled thoracic epidural analgesia (PCTEA), it 
could be the preferred analgesic option in conventional open 
gastrectomy. However, to the best of our knowledge, the effi-
cacy of ITM-IVPCA in patients undergoing gastrectomy 
due to gastric cancer has not yet been investigated. 
We hypothesized that ITM combined with IVPCA is as ef-
fective as PCTEA with respect to postoperative pain control 
after conventional open gastrectomy for stomach cancer. To 
test this hypothesis, we performed the present study designed 
as a randomized, non-inferiority clinical trial, since the aim 
was not to demonstrate superiority of one analgesic regime, 
but to prove that ITM-IVPCA is not worse than PCTEA. 
MATERIALS AND METHODS
　　　
Study population
After obtaining the approval of the Institutional Review 
Board of our institution, participants were recruited from the 
Anesthesiology Preoperative Evaluation Clinic and provid-
ed written informed consent. This investigation was con-
ducted at a single tertiary medical center in Seoul, Korea 
between September 2010 and August 2011. Sixty-four pa-
tients (aged ≥20 yrs, American society of anesthesiologists 
physical status I-II) scheduled to undergo conventional open 
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the postoperative assessments throughout the study period. 
Blinding of the allocated group was ensured because the 
connected part of the PCA pump to the epidural catheter or 
the intravenous line was fixed to the patient and covered by 
the patient’s clothing. Moreover, the PCA pump was in a 
protective bag shielding the medication label on the pump. 
The assessor visited the patients at 1, 3, 6, 24, and 48 hrs af-
ter surgery and assessed VAS of the maximum pain experi-
enced at rest and upon coughing (or moving) since last 
questioning (or recovery from anesthesia). Besides the 
PCA, the total additional fentanyl administration was also 
evaluated.
Adverse effects of analgesia and recovery profiles
Postoperative respiratory depression was defined as less than 
or equal to 8 breaths/min. Postoperative sedation was evalu-
ated using the 8-point modified Ramsey Sedation Scale 
(RSS), and oversedation was defined as RSS greater than 4. 
Patients were excluded from the study and treated with nal-
oxone if they had respiratory depression or oversedation 
persisting for more than 1 hour. Other adverse effects of an-
algesia such as nausea, vomiting, pruritus, and hypotensive 
episode were evaluated until 48 hr after surgery. An objec-
tive motor block was assessed using Bromage score (0=full 
movement, 1=inability to perform straight leg raise in either 
leg, 2=inability to flex either knee, 3=inability to flex either 
ankle) at 6, 24, and 48 hr after surgery. Time to ambulation, 
eating, and flatus was also assessed to compare the recov-
ery profile after surgery. 
Postoperative complications and outcomes
Postoperative management was left to the discretion of the 
Yonsei Gastric Cancer Clinic team. The total amounts of 
intravenous fluid, except total parenteral nutrition, adminis-
tered during the postoperative 48 hr were recorded. The in-
cidence of postoperative complications within postoperative 
day (POD) 30 were assessed, which were also diagnosed 
and treated by the Yonsei Gastric Cancer Clinic team; intra-
peritoneal fluid collection, intraluminal bleeding, postopera-
tive ileus, anastomosis site leakage, pancreatitis, pulmonary 
atelectasis or pleural effusion, pancreatitis and urinary com-
plications were assessed following their protocols.11 
Duration of hospital stay and mortality within 30 days af-
ter operation were recorded as postoperative outcome.
Statistical analysis
The primary outcome variable was a VAS score at rest and 
was then initiated. The patients in the IT group thus re-
ceived basal infusion of fentanyl at 0.4 μg/kg/hr with bolus-
es of 0.04 μg/kg and a lockout period of 15 min. Because 
fentanyl has a relatively short half-life, and thus duration of 
analgesia of boluses is brief, we used the continuous infu-
sion for the IVPCA. In both groups, the infusate for PCA 
were prepared by an anesthesiologist who did not partici-
pate in the postoperative assessment.
To evaluate patient discomfort related to the procedure, 
we assessed the duration of the procedure (from infiltration 
of local anesthetic to removal of the Tuohy needle or spinal 
needle) and subjective grade of discomfort that the patient 
suffered during the procedure (1, minimal; 2, mild; 3, mod-
erate; 4, severe) for both groups. 
Additional intravenous administration of fentanyl (0.4 
μg/kg) upon patient demand was allowed for further anal-
gesia in both groups. After administration of additional fen-
tanyl, respiration rate and the level of consciousness were 
closely monitored for 30 min. In both groups, patients with 
persistent insufficient analgesia (VAS >40) at 30 min after 
post-anesthesia care unit admission were considered as a 
technical failure of epidural or spinal analgesia and thus ex-
cluded from the study. In these patients, a different tech-
nique for analgesia was applied.
Anesthetic procedure
Anesthesia was performed according to the same standard 
protocol in both groups. All patients were premedicated 
with 0.1 mg of glycopyrrolate IV. Anesthesia was induced 
with 1.5 mg/kg of propofol and 1 μg/kg of remifentanil. For 
tracheal intubation, 0.6 mg/kg of rocuronium was given. 
Thereafter, the patient was mechanically ventilated to main-
tain end-tidal carbon dioxide at 35±5 mm Hg during the 
surgery. Anesthesia was maintained with 0.6--1.2 minimum 
alveolar concentration end tidal desflurane in an air-oxygen 
mixture (fraction of inspired oxygen=0.5) and 0.05--0.2 μg/
kg/min remifentanil infusion. The concentration of end-tid-
al desflurane and the infusion rate of remifentanil were ad-
justed according to clinical parameters (blood pressure or 
heart rate within 20% of the baseline). SpO2, heart rate, and 
noninvasive blood pressure were monitored and recorded 
throughout the surgery. For prevention of postoperative 
nausea and vomiting, 0.3 mg of ramosetron was adminis-
tered intravenously at peritoneal closure. 
Pain score and consumption of analgesics
An anesthesiologist blinded to group allocation evaluated 
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Student’s t-tests. Differences between the two groups re-
garding the grade of discomfort during the procedure and 
duration of hospital stay were analyzed by the Mann-Whit-
ney rank-sum test and the incidences of adverse effects, 
postoperative complications, and postoperative outcomes 
were compared using χ2 test or Fisher’s exact test. For these 
variables, a p-value of  <0.05 was considered to be statisti-
cally significant. PASW statistics 18 (SPSS Inc., Chicago, 
IL, USA) and SAS software version 9.2 (SAS, Cary, NC, 
USA) were used to conduct the aforementioned statistical 
analyses.
 
RESULTS
 
A total of 64 patients were randomly allocated to one of the 
two groups (Fig. 1). Among patients in the IT group, one 
was excluded because of persistent oversedation and two 
were excluded due to persisting insufficient analgesia. In 
the EP group, two patients were excluded because of failure 
with placing the epidural catheter and persistent insufficient 
analgesia. The two groups were comparable in terms of pa-
tient characteristics, calculated comorbidity index15 and 
data collected during the perioperative period (Table 1). 
Among the procedure related profiles for intrathecal in-
jection or epidural catheter placement, length of procedure 
was significantly shorter in the IT group than the EP group 
upon coughing 24 hrs after surgery. Therefore, the number of 
patients required for each group was determined according to 
VAS score at 24 hrs after surgery on the basis of the non-in-
feriority hypothesis. For non-inferiority of the IT group ver-
sus the EP group, a maximum difference of 10 (margin of 
non-inferiority) on the VAS scale was considered accept-
able as statistically significant changes of 10 in VAS scores 
are clinically significant in a variety of psychophysiological 
measurements,12 whereas small differences between VAS 
scores may be statistically significant but clinically mean-
ingless.13 On the basis of previously published data,14 a 
standard deviation of 13.6 was assumed for VAS distribu-
tion. Under these conditions, power analysis indicated that 
a sample size of 29 patients for each group would be re-
quired with α=0.025 (one-sided hypothesis) and a power of 
80%. Taking into consideration the potential for drop-outs, 
we decided to enroll 32 patients per group.
The primary outcome variable was analyzed according to 
a non-inferiority approach. The 95% confidence intervals of 
the mean differences in VAS scores, at rest and on coughing, 
between the two treatments 24 hrs after surgery were calcu-
lated and shown in relation to the predefined margin of in-
feriority.
Where appropriate, results were shown as mean (SD) or 
median (interquartile range, IQR). Comparisons of VAS 
scores, total fentanyl consumption, and recovery profiles 
between the two groups were conducted using unpaired 
Fig. 1. CONSORT diagram showing the flow of participants through each stage of our randomized trial. EP, patient-controlled thoracic 
epidural analgesia; IT, intrathecal morphine combined with intravenous patient-controlled analgesia; CONSORT, consolidated standards 
of reporting trials.
Enrollment
Excluded (n=12)
-Not meeting inclusion criteria (n=9)
-Declined to participate (n=3)
-Other reasons (n=0)
Allocated to group IT (n=32)
-Received allocated intervention (n=32)
-Did not receive allocated intervention (n=0)
Lost to follow-up (n=0)
    Discontinued intervention (n=3) due to 
      persisting insufficient analgesia (n=2) and 
      persistent oversedation (n=1)
Analyzed (n=29)
-Excluded from analysis (n=0)
Allocated to group EP (n=32)
-Received allocated intervention (n=31)
-Did not receive allocated intervention (n=1) 
    due to failure of placing epidural catheter
Lost to follow-up (n=0)
    Discontinued intervention (n=1) due to 
      persisting insufficient analgesia
Analyzed (n=30)
-Excluded from analysis (n=0)
Assessed for eligibility (n=76)
Randomized (n=64)
Allocation
Follow-up
Analysis
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The adverse effects of analgesia are presented in Table 2. 
Postoperative nausea developed more frequently in the IT 
group. No motor blockade was detectable in any patient dur-
ing the 48 hr postoperative period (all Bromage score 0). To-
tal amounts of administered fluid during the postoperative 
period of 48 hr were comparable between the two groups 
(4517.0±913.2 mL in the group EP vs. 4666.3±975.6 mL in 
the group IT, mean±SD). Regarding the recovery profiles 
from the surgery, the IT group took 12 hr longer to ambu-
late than the EP group (p=0.02). However, there were no 
differences in time to eating and flatus (Table 3). 
We assessed the postoperative complications and out-
comes documented within POD 30 (Table 4). In the IT 
group, postoperative ileus (p=0.012) and pulmonary com-
plications (p=0.05) developed more frequently, compared 
[4.1±2.4 (min) vs. 6.7±3.2 (min), mean±SD, p=0.013]. 
Grade of discomfort during the procedure was lower in the 
IT group than the EP group [2 (1--2) vs. 3 (2--3), median 
(IQR), p=0.004].
VAS scores at rest (Fig. 2A) and on coughing (Fig. 2B) 
until 48 hr after surgery were statistically comparable for 
both the IT and EP groups. However, the 95% confidence 
interval of the mean differences in VAS scores between the 
two groups at rest and on coughing at 24 hrs after surgery 
included the upper margin of equivalence, and thus, this 
study failed to demonstrate non-inferiority of intrathecal 
morphine administration to PCTEA (Fig. 3). The total fen-
tanyl consumption up to 48 hrs postoperatively was signifi-
cantly greater in the IT group than the EP group (1247.2± 
263.7 μg vs. 1048.9±71.7 μg, p<0.001).
Table 1. Patient Characteristics and Data from the Perioperative Period
Group EP (n=30) Group IT (n=29)
Age (yrs)   53.8±9.8     55.6±10.1
Gender (M/F) 20/10 17/12
Height (cm) 164.5±6.6 162.6±6.8
Weight (kg)   64.4±9.6     61.4±11.3
ASA class (I/II) 22/8 20/9
CCI (0/1 or 2) 24/6 20/9
Smoking history (non/past/active) 18/7/5 15/9/5
RSTG/RTG 24/6 23/6
Amount of fluids during surgery (mL)   1633.3±692.2   1548.4±533.8
Blood loss during surgery (mL)     148.0±249.4     148.4±255.1
Urine output during surgery (mL)     207.3±183.1     220.3±149.6
Duration of anesthesia (min)   198.6±50.1   196.9±48.3
Duration of surgery (min)   164.9±39.6   166.9±38.2
IT, intrathecal morphine combined with intravenous patient-controlled analgesia; ASA, American society of anesthesiologists; CCI, calculated co-morbidi-
ties index; RSTG, radical subtotal gastrectomy; RTG, radical total gastrectomy; EP, patient-controlled thoracic epidural analgesia.
Data were shown as mean±SD or number of patients. 
Fig. 2. VAS scores of maximum pain experienced since last questioning (or recovery from anesthesia) (A) at rest and (B) on coughing. The VAS scores were 
compared using unpaired Student’s t-tests. VAS, visual analogue scale; EP, patient-controlled thoracic epidural analgesia; IT, intrathecal morphine com-
bined with intravenous patient-controlled analgesia.
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DISCUSSION
The present study revealed that the analgesic effect of sin-
gle intrathecal morphine injection combined with IVPCA is 
to the EP group. However, although the incidence of post-
operative complications was higher in the IT group than in 
the EP group, there were no statistically significant differ-
ences in hospital stay (p=0.14). Moreover, there was no 
mortality within POD 30 in both groups.
Fig. 3. Mean differences in VAS scores of maximum pain experienced at 24 hours after surgery. Error bars indicate two-sided 95% confidence intervals 
(CIs). As the CIs include Δ and zero, the difference was non-significant, and the results regarding non-inferiority were inconclusive. Δ, margin of non-inferi-
ority. Non-tinged area indicates zone of inferiority. ITM-IVPCA, intrathecal morphine combined with intravenous patient-controlled analgesia; VAS, visual 
analogue scale; PCTEA, patient-controlled thoracic epidural analgesia.
Table 2. Profiles of Opioid and Local Anesthetics Related Adverse Effects between the Two Groups
Group EP (n=30) Group IT (n=29) p value
Nausea (%) 4 (13.3) 13 (44.8) 0.010
Vomiting (%) 0   4 (13.8) 0.052
Pruritus (%) 4 (13.3)   5 (17.2) 0.731
Hypotensive episode (%) 7 (23.3)   4 (13.8) 0.506
EP, patient-controlled thoracic epidural analgesia; IT, intrathecal morphine combined with intravenous patient-controlled analgesia.
Data were shown as number of patients (proportion, %). 
Table 3. Comparison of Recovery Profiles between the Groups
Group EP Group IT p value
Time to ambulation (hrs)   32.6±16.0  45.4±25.1 0.021
Time to eating (hrs)   78.4±23.3  83.1±21.1 0.411
Time to flatus (hrs) 100.9±21.1  99.3±19.9 0.762
EP, patient-controlled thoracic epidural analgesia; IT, intrathecal morphine combined with intravenous patient-controlled analgesia.
Data were shown as mean±SD. 
Table 4. Postoperative Complications and Outcomes Within Postoperative Day 30
Group EP (n=30) Group IT (n=29) p value
The number of patients with
    Fluid collection (%)   9 (30.0)    9 (31.0) 0.931
    Intraluminal bleeding (%)   9 (30.0)    4 (13.8) 0.209
    Ileus (%) 1 (3.3)    8 (27.6) 0.012
    Anastomosis site leakage (%) 1 (3.3)  1 (3.4) 1.000
    Pancreatitis (%)   6 (20.0)    9 (31.0) 0.330
    Pulmonary complications (%)   9 (30.0)  16 (55.2) 0.050
    Urinary complications (%) 20 (66.7)  23 (79.3) 0.275
Hospital stay (days)     8 (8--8.3)  8.5 (8--10) 0.140
Re-admission 2 1 1.0
Re-operation 0 0 NA
Mortality 0 0 NA
EP, patient-controlled thoracic epidural analgesia; IT, intrathecal morphine combined with intravenous patient-controlled analgesia; NA, not applicable.
Data were shown as number of patients (proportion, %) or median (interquartile range). 
← ITM-IVPCA better ITM-IVPCA worse →
Mean treatment differences for VAS scores on 24 hr after surgery (ITM-IVPCA minus PCTEA)
-30 -20 -10 0 Δ=10 20 30
VAS score on coughing
VAS score at rest
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outcomes.
As the secondary endpoint, we demonstrated that PCTEA 
is associated with the reduced incidence of postoperative ile-
us and pulmonary complication after gastrectomy. Postoper-
ative ileus is a major gastrointestinal complication of ab-
dominal surgery, leading to increased rates of morbidity and 
mortality, longer lengths of hospital stay, and higher costs.20 
Gastrointestinal hypomotility, caused by surgical reflex via 
inflammatory cascades, leads to postoperative ileus. TEA 
could increase gastrointestinal activity and improve postoper-
ative ileus without increasing the risk of anastomotic leak-
age.21 Additionally, there is evidence that TEA preserves pul-
monary function better than other analgesic techniques.22-24 
The decreased incidence of pulmonary complications in the 
PCTEA group in this study may have resulted from better 
preservation of pulmonary function by the PCTEA than by 
the ITM-IVPCA.
Conversely, Levy, et al.5 reported that epidural analgesia 
in patients undergoing laparoscopic colorectal surgery in-
creased the time to return bowel function and showed simi-
lar pulmonary function compared to spinal analgesia in their 
prospective randomized controlled trial. These differences 
from our results may be because of a characteristic of the 
colorectal surgery or the analgesic regimen. However, in 
their study, the epidural analgesia group received more in-
travenous fluid than the spinal analgesia group throughout 
the peri-operative period and had a small degree of motor 
blockade, which could inhibit early mobility. Excessive flu-
id administration could lead to edematous bowel and lungs, 
which consequently causes ileus and adverse respiratory 
function.25 Immobility can also prevent enhanced recovery.26 
In other retrospective investigations in which ITM shortened 
hospital stay compared with epidural analgesia, epidural an-
algesia was also associated with a larger amount of intravas-
cular fluid administration or limited ambulation.3,4 However, 
our results show that fluid overload and motor blockade 
during epidural analgesia are avoidable. Therefore, when 
attempting to elucidate the effects of analgesic techniques 
on postoperative complications or outcomes, one should 
consider the influences of fluid administration and preser-
vation of ambulation. 
This study had several limitations. First, according to the 
allocated group, participants in our study received different 
kinds of analgesic medication (morphine and fentanyl vs. 
ropivacaine and fentanyl) via different routes (intrathecal 
route combined with intravenous route vs. epidural route). 
Because 0.3 mg of intrathecal morphine combined with 20 
not as effective as the analgesic effect of PCTEA in patients 
undergoing gastrectomy. The treatment differences in terms 
of VAS scores failed to demonstrate the non-inferiority of 
ITM-IVPCA at 24 hrs after the operation compared to PC-
TEA, despite no significant difference in VAS scores. How-
ever, the IT group consumed a larger amount of fentanyl 
than the EP group did. Furthermore, ITM-IVPCA was as-
sociated with a longer time to ambulation, and, eventually, 
an increased incidence of postoperative ileus and pulmo-
nary complication.
In a meta-analysis, a wide range of dose of intrathecal 
morphine (0.1--4 mg) have been tested in various types of 
surgery.16 According to recent reports, intrathecal adminis-
tration of 0.2--0.4 mg of morphine improves postoperative 
analgesia without respiratory depression after major ab-
dominal surgery.1,17 Therefore, we selected 0.3 mg for intra-
thecal morphine in the present study. Additionally, intrathe-
cal morphine administration was reported to decrease VAS 
up to postoperative 24 hr and reduce opioid requirement up 
to postoperative 48 hr.16 To demonstrate the non-inferiority 
of the analgesic effect of ITM-IVPCA over PCTEA, it was 
thought that the VAS at 24 hrs after surgery should be com-
pared between both groups. Therefore, we set VAS score at 
postoperative 24 hr as the primary endpoint.
It is well known that continuous epidural analgesia is supe-
rior to opioid IVPCA in relieving postoperative pain in pa-
tients undergoing abdominal surgery6 including gastrectomy.18 
Also, ITM-IVPCA has been reported to reduce postoperative 
opioid consumption and improve analgesic effect over IVP-
CA alone.1,19 However, until now, only a few comparative 
studies between ITM and thoracic epidural analgesia (TEA) 
have been undertaken. De Pietri, et al.17 demonstrated that, in 
hepatectomies, ITM-IVPCA provided comparable pain re-
lief to continuous epidural analgesia up to 48 hours after 
surgery and ITM-IVPCA was proven as a valid alternative 
to epidural analgesia. However, they revealed that the EP 
group took a longer time to require first analgesics and con-
sumed less morphine IVPCA, while postoperative nausea 
and vomiting occurred less frequently, compared to the IT 
group. These findings are in agreement with our study, which 
demonstrated that the EP group required less additional fen-
tanyl and less postoperative nausea occurred. Therefore, con-
tinuous epidural analgesia seems to have advantages over 
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μg/kg of fentanyl in IVPCA has not been proven to have 
potentially equivalent analgesia to 1000 μg of fentanyl 
mixed with 0.2% ropivacaine in PCTEA, adopted doses 
and types of opioids and local anesthetic in our study may 
affect our results. However, the objective of our study was 
to compare the two analgesic methods, not to find the ap-
propriate doses or types of analgesic agent for each analge-
sic method. Therefore, we selected conventional doses of 
the medications for each analgesic method. Previous stud-
ies that compared the analgesic efficacy between different 
analgesic methods also did not consider equivalent doses 
for analgesic effect between different medications, but ad-
opted conventional types and doses of analgesic medication 
for each analgesic method.17,23 Second, in spite of lower in-
cidences of postoperative ileus and pulmonary complication 
in the PCTEA group, we could not show that PCTEA short-
ened hospital stay. This may be because our study does not 
have sufficient power for secondary endpoints such as post-
operative outcome. Finally, we did not perform sham blocks 
in the both groups. Therefore, the present study is not dou-
ble blind. 
In conclusion, analgesia with ITM-IVPCA is not as effec-
tive as that of PCTEA, considering the treatment differences 
in terms of VAS scores failed to demonstrate the non-inferior-
ity of ITM-IVPCA compared to PCTEA. Furthermore, ITM-
IVPCA required the higher amount of opioids compared to 
PCTEA. Moreover, ITM-IVPCA was associated with a lon-
ger time to ambulation, an increased incidence of postopera-
tive ileus and pulmonary complication. Therefore, ITM-IVP-
CA may not be preferred analgesic technique to PCTEA in 
patients undergoing conventional open gastrectomy. 
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